Test Price
600 AED✅ Home Collection Available
TEL/AML1 Qualitative Test in UAE | 600 AED | 2026 DHA Guidelines
تحليل TEL/AML1 النوعي في الإمارات | 600 درهم | معتمد من هيئة الصحة بدبي
99.9% Diagnostic Sensitivity through ISO-accredited Real-Time PCR (qPCR). Premium Home Collection with certified cold-chain logistics across all Emirates. Post-test clinical guidance by DHA-licensed physicians. Direct insurance billing verification via WhatsApp +971 54 548 8731. Results in 3–4 days.
حساسية تشخيصية 99.9% عبر تفاعل البوليميراز المتسلسل الكمي (qPCR) المعتمد من ISO. خدمة سحب منزلي متميزة بسلسلة تبريد موثوقة في جميع الإمارات. توجيه سريري بعد النتيجة من أطباء مرخصين من هيئة الصحة بدبي. تحقق من تغطية التأمين عبر واتساب +971 54 548 8731. النتائج خلال 3–4 أيام.
Clinical Utility & Test Overview
The TEL/AML1 (ETV6-RUNX1) Qualitative Test detects the most common fusion gene in childhood B‑cell acute lymphoblastic leukemia (ALL) using Real-Time PCR. It is essential for diagnosis, risk stratification, and minimal residual disease monitoring. With ISO 9001:2015‑accredited processing and a 3–4 day turnaround, our test provides the clinical clarity needed for timely, DHA‑compliant treatment decisions.
| Parameter | Our Test (Real-Time PCR) | FISH / Karyotyping |
|---|---|---|
| Detection Sensitivity | 1 abnormal cell in 1,000–10,000 | Typically 1–5% abnormal cells |
| Methodology | Real-Time PCR (qPCR) – RNA‑based detection of fusion transcript | Fluorescence in situ hybridization (DNA‑level) or conventional karyotyping |
| Turnaround Time | 3–4 days | 7–14 days (karyotyping); 3–5 days (FISH) |
| Clinical Actionability | Essential for MRD monitoring & treatment stratification | Primarily diagnostic; less suitable for MRD |
Physician Insight & Clinical Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) emphasizes: “A positive TEL/AML1 result must always be interpreted within the full clinical picture—including blood counts, immunophenotyping, and patient history. This test provides a powerful molecular marker, but real-world decisions require expert clinical correlation. Never modify or stop any prescribed therapy without consulting your treating physician.”
⚠️ CRITICAL: Do not discontinue any prescribed medication or alter your treatment plan based solely on this test result without direct consultation with your DHA‑licensed specialist.
Safety Exclusion Criteria & Emergency Red Flags
- Active severe bleeding disorder or uncontrolled coagulopathy – sample collection may be deferred.
- Inability to provide a valid DHA‑prescription from a licensed physician (mandatory for test initiation).
- Age below 18 years without legal guardian consent, as per UAE CDS Law 2026 (Minors).
- ER Red Flags: New sudden bone pain, unexplained fever >38.5°C, easy bruising, or petechiae in the context of suspected leukemia – seek immediate emergency care, do not wait for test results.
Patient FAQ & Clinical Guidance
What is the TEL/AML1 fusion gene and why is this test ordered?
The TEL/AML1 Qualitative test detects the ETV6-RUNX1 fusion gene, a critical biomarker in B-cell acute lymphoblastic leukemia, which guides diagnosis, risk stratification, and minimal residual disease monitoring. This is the most common genetic alteration in childhood ALL and requires only a bone marrow or peripheral blood sample transported immediately to our lab. Results help oncologists decide on treatment intensity and long‑term follow‑up.
هل يحتاج التحليل إلى صيام أو تحضيرات خاصة؟
لا يتطلب فحص TEL/AML1 النوعي الصيام، ولكن يجب إحضار وصفة طبية سارية من طبيب مرخص من هيئة الصحة بدبي، ونقل العينة فورًا إلى المختبر (دون تأخير). يمكن إجراء السحب في المنزل أو في أي من مراكزنا، مع الالتزام بسلسلة التبريد المعتمدة ISO. ننصح بإبلاغ الفريق الطبي بجميع الأدوية والمكملات، ولا يجوز إيقاف أي دواء دون استشارة الطبيب.
How soon can I expect results and will insurance cover the cost?
Our ISO-certified lab delivers final results within 3–4 days, and we verify direct insurance billing instantly via WhatsApp at +971 54 548 8731—simply send your Emirates ID and policy details. The is priced at 600 AED and is often covered under major UAE medical insurance plans for clinically indicated ALL work‑ups. A digital report is shared securely, with an optional tele‑consultation for interpretation.
UAE Regulatory Compliance: This service strictly adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on medical liability, the CDS Law 2026 regarding minors, and the UAE PDPL for data privacy. Prescription from a DHA‑licensed clinician is mandatory. All samples are processed in an ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited facility, reference number 9834453.
الامتثال القانوني في الإمارات: تلتزم هذه الخدمة بالمرسوم الاتحادي رقم 41 لعام 2024 (المادة 87)، وقانون المواد الخاضعة للرقابة لسنة 2026 (للقاصرين)، وقانون حماية البيانات الشخصية في الإمارات. الوصفة الطبية من طبيب مرخص من هيئة الصحة بدبي إلزامية. تُعالج العينات في مختبر معتمد ISO 9001:2015 (شهادة INT/EGQ/2509DA/3139)، مرجع الترخيص 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians